INTRODUCTION: Puumala virus (PUUV) infection is a viral hemorrhagic fever with renal syndrome (HFRS) characterized by thrombocytopenia and acute impairment of renal function. We aimed to assess whether genetic polymorphisms of platelet antigens together with those of von Willebrand factor (VWF) and plasminogen activator inhibitor (PAI-1) correlate with disease severity. Patients and methods 172 consecutive hospital-treated patients with serologically confirmed acute PUUV infection were included. Platelet glycoprotein (GP) IIIa T>C (rs5918), GP Ia T>C (rs1126643), GP Ib C>T (rs6065), GP VI T>C (rs1613662), VWF A>G (rs1063856) and PAI-1 A>G (rs2227631) were genotyped. The associations of the rarer alleles with variables reflecting the severity of the disease were analyzed. RESULTS: PAI-1G-carriers had higher maximum creatinine level compared with the non-carriers (median 213 μmol/l, range 60-1499 μmol/l vs. median 122 μmol/l, range 51-1156 μmol/l, p = 0.01). The GG-genotypes had higher creatinine levels than GA- and AA-genotypes (medians 249 μmol/l, 204 μmol/l and 122 μmol/l, respectively, p = 0.03). Polymorphisms of GP VI and VWF associated with lower creatinine levels during PUUV infection. The minor C-allele of GP Ia associated with lower platelet counts (median 44 × 10(9)/l, range 20-90 × 10(9)/l vs median 64 × 10(9)/l, range 3-238 × 10(9)/l; p = 0.02). CONCLUSIONS: Polymorphism of PAI-1, a major regulator of fibrinolysis, has an adverse impact on the outcome of kidney function in PUUV-HFRS. Platelet collagen receptor GP Ia polymorphism associates with lower platelet count.
INTRODUCTION:Puumala virus (PUUV) infection is a viral hemorrhagic fever with renal syndrome (HFRS) characterized by thrombocytopenia and acute impairment of renal function. We aimed to assess whether genetic polymorphisms of platelet antigens together with those of von Willebrand factor (VWF) and plasminogen activator inhibitor (PAI-1) correlate with disease severity. Patients and methods 172 consecutive hospital-treated patients with serologically confirmed acute PUUV infection were included. Platelet glycoprotein (GP) IIIa T>C (rs5918), GP Ia T>C (rs1126643), GP Ib C>T (rs6065), GP VI T>C (rs1613662), VWF A>G (rs1063856) and PAI-1 A>G (rs2227631) were genotyped. The associations of the rarer alleles with variables reflecting the severity of the disease were analyzed. RESULTS: PAI-1G-carriers had higher maximum creatinine level compared with the non-carriers (median 213 μmol/l, range 60-1499 μmol/l vs. median 122 μmol/l, range 51-1156 μmol/l, p = 0.01). The GG-genotypes had higher creatinine levels than GA- and AA-genotypes (medians 249 μmol/l, 204 μmol/l and 122 μmol/l, respectively, p = 0.03). Polymorphisms of GP VI and VWF associated with lower creatinine levels during PUUV infection. The minor C-allele of GP Ia associated with lower platelet counts (median 44 × 10(9)/l, range 20-90 × 10(9)/l vs median 64 × 10(9)/l, range 3-238 × 10(9)/l; p = 0.02). CONCLUSIONS: Polymorphism of PAI-1, a major regulator of fibrinolysis, has an adverse impact on the outcome of kidney function in PUUV-HFRS. Platelet collagen receptor GP Ia polymorphism associates with lower platelet count.
Authors: Lotta Joutsi-Korhonen; Peter A Smethurst; Angela Rankin; Elaine Gray; Martin IJsseldijk; Catherine M Onley; Nicholas A Watkins; Lorna M Williamson; Alison H Goodall; Philip G de Groot; Richard W Farndale; Willem H Ouwehand Journal: Blood Date: 2003-01-30 Impact factor: 22.113
Authors: Aino Lepäntalo; Jussi Mikkelsson; Julio C Reséndiz; Leena Viiri; Janne T Backman; Esko Kankuri; Pekka J Karhunen; Riitta Lassila Journal: Thromb Haemost Date: 2006-02 Impact factor: 5.249
Authors: A T A Mairuhu; T E Setiati; P Koraka; C E Hack; A Leyte; S M H Faradz; H ten Cate; D P M Brandjes; A D M E Osterhaus; P H Reitsma; E C M van Gorp Journal: Thromb J Date: 2005-11-07
Authors: Antti Vaheri; Tomas Strandin; Jussi Hepojoki; Tarja Sironen; Heikki Henttonen; Satu Mäkelä; Jukka Mustonen Journal: Nat Rev Microbiol Date: 2013-08 Impact factor: 60.633
Authors: Virginie Bondu; Ron Schrader; Mary Ann Gawinowicz; Paul McGuire; Daniel A Lawrence; Brian Hjelle; Tione Buranda Journal: Viruses Date: 2015-02-10 Impact factor: 5.048
Authors: Tuula K Outinen; Laura Tervo; Satu Mäkelä; Reetta Huttunen; Niina Mäenpää; Heini Huhtala; Antti Vaheri; Jukka Mustonen; Janne Aittoniemi Journal: PLoS One Date: 2013-08-21 Impact factor: 3.240
Authors: Nathalie Charbonnel; Marie Pagès; Tarja Sironen; Heikki Henttonen; Olli Vapalahti; Jukka Mustonen; Antti Vaheri Journal: Viruses Date: 2014-05-26 Impact factor: 5.048
Authors: Marco Goeijenbier; Joost C M Meijers; Fatih Anfasa; Jeroen M Roose; Cornelia A M van de Weg; Kamran Bakhtiari; Heikki Henttonen; Antti Vaheri; Albert D M E Osterhaus; Eric C M van Gorp; Byron E E Martina Journal: Front Microbiol Date: 2015-03-24 Impact factor: 5.640
Authors: Tuula K Outinen; Paula Mantula; Pia Jaatinen; Mari Hämäläinen; Eeva Moilanen; Antti Vaheri; Heini Huhtala; Satu Mäkelä; Jukka Mustonen Journal: Viruses Date: 2019-08-21 Impact factor: 5.048
Authors: Sirpa Koskela; Outi Laine; Satu Mäkelä; Tanja Pessi; Sari Tuomisto; Heini Huhtala; Pekka J Karhunen; Ilkka Pörsti; Jukka Mustonen Journal: PLoS One Date: 2015-11-11 Impact factor: 3.240